2024-03-20
AACR 2024 Abstract #6050
2023-02-22
Discovery of Prodrug of MRTX1133 as an Oral Therapy for Cancers with KRASG12D Mutation
2022-12-12
A Dual-Specificity Inhibitor Targets Polyphosphate Kinase
Shanghai Zhangjiang R&D Center.
Suzhou Industrial Park R&D Center.
Shanghai Lingang Industrial Base.
send mail
Copyright 2022 Risen(Shanghai) Pharma Tech Co., Ltd. All Rights Reserved 沪ICP备16020731号-1 Design by:yushangweb